X @The Wall Street Journal

Exclusive: Johnson & Johnson is in talks to buy Protagonist Therapeutics in a deal that would solidify the companies’ existing partnership in creating a treatment for ulcerative colitis https://t.co/BNb7Po7tF7 ...